Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.879062563491146.3508
Domestic EquitiesDivi's Laboratories Limited9.57171298808790.5844
Domestic EquitiesLupin Limited6.30232483991520.5452
Domestic EquitiesCipla Limited6.00553200000496.0320
Domestic EquitiesApollo Hospitals Enterprise Limited5.4805648795452.6643
Domestic EquitiesDr. Reddy's Laboratories Limited5.24923662170433.5643
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited3.63211011921299.9941
Domestic EquitiesMedPlus Health Services Limited3.54033627277292.4129
Domestic EquitiesVijaya Diagnostic Centre Limited3.42992831564283.2980
Domestic EquitiesAbbott India Limited3.226788883266.5157
Domestic EquitiesAjanta Pharma Limited3.1430959323259.6024
Domestic EquitiesNarayana Hrudayalaya Limited3.03981426170251.0772
Domestic EquitiesGland Pharma Limited2.59221529352214.1093
Domestic EquitiesAurobindo Pharma Limited2.53371702630209.2703
Domestic EquitiesDr. Lal Path Labs Limited2.3774709112196.3602
Domestic EquitiesZydus Lifesciences Limited2.15152000632177.7061
Domestic EquitiesTorrent Pharmaceuticals Limited2.0245503364167.2175
Domestic EquitiesAlkem Laboratories Limited2.0049323678165.5937
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited1.9515999649161.1834
Domestic EquitiesMankind Pharma Limited1.9372649036160.0068
Domestic EquitiesThyrocare Technologies Limited1.87731765838155.0582
Domestic EquitiesSanofi India Limited1.6569230272136.8506
Domestic EquitiesPfizer Limited1.6540318249136.6179
Domestic EquitiesIPCA Laboratories Limited1.3324785412110.0519
Domestic EquitiesSanofi Consumer Healthcare India Limited1.2779213659105.5475
Domestic EquitiesSai Life Sciences Limited1.2067143042399.6719
Domestic EquitiesSuraksha Diagnostic Limited1.1482316961894.8350
Domestic EquitiesFortis Healthcare Limited0.9162110388975.6771
Domestic EquitiesBiocon Limited0.8899228422273.5063
Domestic EquitiesSyngene International Limited0.8635112479571.3176
Domestic EquitiesAstraZeneca Pharma India Limited0.67356407855.6261
Domestic EquitiesIndoco Remedies Limited0.5167183492442.6748
Domestic EquitiesOrchid Pharma Limited0.477849272739.4674
Domestic EquitiesEmcure Pharmaceuticals Limited0.373430184130.8451
Domestic EquitiesKrishna Institute Of Medical Sciences Limited0.367246178530.3323
Domestic EquitiesConcord Biotech Limited0.205411173816.9685
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.198131330516.3608
Total 99.7082 8235.4976
Cash & Cash Equivalents and Net AssetsTriparty Repo0.3605 29.7774
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0022 0.1848
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.0709 -5.8570
Total 0.2918 24.1052
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.